Rett syndrome is an X linked dominant neurodevelopmental disorder which almost exclusively affects females. The syndrome is usually caused by mutations in MECP2 gene, which is a nuclear protein that selectively binds CpG dinucleotides in the genome.
Introduction
Rett syndrome, is a severe X linked dominant neurodevelopmental disorder that predominantly affects females, and has been considered lethal to males (1, 2) .
Typically, this syndrome is characterized by apparently normal development during the first 6 months of life, followed by rapid deterioration with regression of social, motor, and communication skills (1) . Clinical features also include microcephaly, seizures, stereotypical hand movements, scoliosis, ataxia, intellectual disability, and little or no verbal skills (3) . Rett syndrome is usually due to mutations in the MECP2 gene, located on chromosome X (Xq28) and encodes a methyl-CpG binding protein 2 (MECP2) (1) . MECP2 is a nuclear protein that selectively binds CpG dinucleotides in the mammalian genome and may act as a silencer of gene expression interacting with other proteins such as histone deacetylase complex and the transcriptional corepressor sin3A (4) . The majority of Rett patients have mutations in exons 3 or 4, which encode the MECP2 functional domains, the MBD and the TRD domain, respectively (1) .
To provide further insights into the spectrum and distribution of mutations in MECP2 gene, we performed sequencing of the entire MECP2 coding regions and splice sites in 24 female cases with clinical characteristics of Rett syndrome from the Iranian population. Clinical details of each patient were recorded by neurologists ( Table 2) .
Materials and Methods

Molecular
We prepared genomic DNA from peripheral blood leukocytes of patients by the standard salting-out method (8) . PCR was performed for exons 1, 2, 3, and 4 using primer pairs reported in Table 3 . For (Table 4 ). Although the spectrum of mutations is very heterogeneous, mutations mainly occur in exon 4, which points to mutational hotspots in MECP2 gene.
In order to find out the functional consequences of this new missense mutation, we performed in silico analyses with JALVIEW, SIFT (http://sift.jcvi.org/) and PolyPhen (http://genetics.bwh.harvard.edu/ pph2/). c.218 C>A is pathogenic. Multiple alignments of the sequences using Jalview showed that the amino acid position in exon 3 is physicochemically conserved in mammals ( Figure 1 ). (14) Necessary criteria (1)Apparently normal prenatal and perinatal period (2)Apparently normal psychomotor development through the first 6 months (3)Normal head circumference at birth (4)Deceleration of head growth between the ages of 5 months and 4 yr (5)Loss of acquired purposeful hand skills between the ages of 6 and 30 months, temporally associated with communication dysfunction and social withdrawal (6)Development of severely impaired expressive and receptive language, and presence of apparent severe psychomotor retardation. (7) Stereotypic hand movements such as hand wringing/squeezing, clapping/tapping, mouthing and washing/rubbing automatisms appearing after purposeful hand skills are lost (8)Appearance of gait apraxia and truncal apraxia/ataxia between ages 1 and 4 yr of age (9)Diagnosis tentative until 2-5 yr of age Figure 1 . Analysis by Jalview showed that amino acid 73 is conserved in mammals 
Discussion
With the discovery of mutations in MECP2 gene, RTT became the first human disease to be caused by mutations in a gene encoding a factor that has role in the epigenetic silencing machinery (9) .
In our study, three of the thirteen patients with MECP2 mutations had one of the nonsense mutations reported by Wan et al (9) . Two of them had the R168X mutation, which encodes a truncated MECP2 protein containing only the MBD and lacking the TRD, the nuclear localization signal and the C-terminal region (11) .
Since the R168X mutation is within the last exon, between the MBD and TRD, it is not expected to In this study, we identified 3 novel mutations. varied among different studies which was between 23-90% (4, 9, 10) . In this study, 54% of patients had MECP2 mutations, which is similar to another study (9) . Among the molecular defects reported in this study, four are missense mutations, two are nonsense mutations, three are deletions and one is a complex deletion/insertion. Mutations mainly occur in exon 4 and the multiple recurrences of R168X (two times) and R306C (three times), points to true mutational hotspots. These two recurring mutations account for 38% (5 of 13) of all mutation-positive cases. We described three novel mutations not reported previously and are most likely pathogenic.
To date, more than 250 mutations have been identified in MECP2, although eight specific mutations (R106W, P152R, T158M, R168X, R255X, R270X, R288X, and R306C) are found in more than 60% of individuals with RTT (21, 22) .
Most of the mutations are C>T transitions, which are located in the MBD, TRD or ID. 
